Description
Clinically tested Class IIa Medical Device that works thanks to Policaptil Gel Retard, a patented complex of polysaccharide macromolecules.
Policaptil Gel Retard acts at the intestinal level by forming a highly viscous gel that helps control postprandial glycemic peaks by reducing the quantity and speed of carbohydrate absorption (retard effect). This also reduces the feeling of hunger and postprandial drowsiness.
Furthermore, with the same mechanism, Policaptil Gel Retard limits the absorption of fats, promotes intestinal transit and regulates stool consistency.
Thanks to its mechanism of action, Libramed is indicated for:
1. Adults and children aged 12 and over
• In case of overweight and obesity
• With high abdominal circumference values, even normal weight
2. Children aged 8 and over
• In case of overweight and obesity
The product is most effective when combined with a balanced diet, adequate fluid intake, and regular physical activity.

How to use
- Adults and children over 12 years: 3 tablets before the two main meals.
- Children between 8 and 12 years: 2 tablets before the two main meals.

Take the indicated dose with a large glass of water, taking care to swallow one tablet at a time. Do not chew or break the tablet with your teeth.
For those with swallowing problems, Libramed tablets can be dissolved in warm water or unsweetened herbal tea, stirring until completely dissolved. The resulting drink should be consumed within a few minutes, before a gel forms.

Take Libramed for a period of at least 2 months, taking care to stop for 2-3 days after each month of treatment.

Components
Patented complex of polysaccharide macromolecules (Policaptil Gel Retard); Orange, Apple and Lemon flavours.

Policaptil Gel Retard is a patented macromolecular complex created using a production technology that allows for the concentration of specific polysaccharide fractions obtained from: Cellulose, Opuntia Ficus indica, Amorphophallus konjac, Althaea officinalis, Linum usitatissimum, Tilia platyphyllos, Cichorium intybus.

Warnings
For those who have swallowing problems, direct ingestion of the tablets is not recommended; they must be dissolved first.
It is recommended to take the product at least two hours after taking medications to avoid a possible interaction with their absorption.
Do not take during pregnancy or breastfeeding.
In subjects undergoing drug treatment for diabetes and hyperlipidemia, it is advisable to consult a doctor to evaluate the need for a possible change in drug dosages.
Do not use if you have hypersensitivity or individual allergy to one or more components.
Keep out of reach of children.
The safety of Libramed has been confirmed through clinical studies conducted in adults and children, which demonstrated excellent tolerability. Taking Libramed did not cause alterations in key blood and urine values. During the first few days of use, bloating may occur, which resolves spontaneously as treatment continues. In these cases, it is recommended to reduce the dosage to one tablet twice daily and gradually increase it until the recommended dose is reached.

Conservation
Store at room temperature, away from heat sources and protected from light.
The expiration date refers to the intact and properly stored product. Do not use after the indicated expiration date.
Shelf life in intact packaging: 36 months.

Format
Bottle of 138 swallowable tablets of 725 mg each.

Cod. DIMADCOX